The government is investigating reports of generic versions of some medicines being manufactured without proper testing, Health Minister J.P. Nadda Friday told parliament.
In a written reply in the Lok Sabha, Nadda said that the government was aware of the reports regarding manufacturing of generic versions of some drugs without proper testing.
"The Indian Council of Medical Research has taken up the matter with the Drug Controller General of India (DCGI) for action against such erring companies," he said.
"Action as permissible under the Drugs and Cosmetics Act, 1940 and the rules made there under will be taken by Drugs Controller General (India) after verification of facts," he added.
The manufacture for sale of drugs is regulated through a system of inspection and licensing under the provisions of Drugs and Cosmetics Act, 1940.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app